AssayIndex
Reports by quarter

Reports submitted in 2026-Q3

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.92 % area, n=453. Read the 2026-Q3 state-of-the-index report →

453 records12 pagesmedian on this page 98.81 %updated 30 Jul 2026
017345192.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=195.50–95.75 %: n=295.75–96.00 %: n=296.00–96.25 %: n=696.25–96.50 %: n=796.50–96.75 %: n=496.75–97.00 %: n=997.00–97.25 %: n=797.25–97.50 %: n=1097.50–97.75 %: n=1397.75–98.00 %: n=1998.00–98.25 %: n=3098.25–98.50 %: n=4298.50–98.75 %: n=4598.75–99.00 %: n=4299.00–99.25 %: n=5499.25–99.50 %: n=5899.50–99.75 %: n=5699.75–100.00 %: n=46median 98.92 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2026-Q3. n=453, median 98.92 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042737SelankGGPepsGGPE-2603-J9708Janoshik2026-Q398.409.1497.4Buyer-sourced0FAIL
AX-2026-041847TB-500JEEPJEEP-2602-V3434Nordanalyt2026-Q399.723.85—Supplier-supplied1MARGINAL
AX-2026-041275LiraglutideWWBWWB-2607-X2189Nordanalyt2026-Q399.615.0397.3Supplier-supplied0PASS
AX-2026-042461Kisspeptin-10SWBSWB-2603-D6238Janoshik2026-Q398.354.6596.5Supplier-supplied3FAIL
AX-2026-041683CJC-1295 (no DAC)QSCQSC-2606-V8637Janoshik2026-Q399.933.6397.1Supplier-supplied1FAIL
AX-2026-043368N-Acetyl Semax AmideCPCCPC-2602-D2941Medutest2026-Q398.796.05102.1Supplier-supplied0PASS
AX-2026-042804SelankGGPepsGGPE-2602-G2056Janoshik2026-Q398.507.97—Supplier-supplied0FAIL
AX-2026-041727CJC-1295 with DACQSCQSC-2602-E9474Janoshik2026-Q398.886.62105.3Supplier-supplied1MARGINAL
AX-2026-041387BPC-157WWBWWB-2606-H3906Janoshik2026-Q398.954.64—Laboratory-retained1MARGINAL
AX-2026-041334SemaglutideWWBWWB-2606-N3192Janoshik2026-Q398.835.04—Supplier-supplied1MARGINAL
AX-2026-041932SemaglutideTFCTFC-2604-X4301Janoshik2026-Q398.884.31—Supplier-supplied0PASS
AX-2026-043029RetatrutideKPKP-2607-H5219Medutest2026-Q395.455.71—Supplier-supplied2FAIL
AX-2026-042803SelankGGPepsGGPE-2602-G2056Janoshik2026-Q398.488.01—Laboratory-retained1FAIL
AX-2026-043335LiraglutideCPCCPC-2602-G1978Janoshik2026-Q397.294.91—Laboratory-retained1FAIL
AX-2026-043176Kisspeptin-10GL BiochemGLBI-2608-N8085Medutest2026-Q398.223.3092.5Buyer-sourced2FAIL
AX-2026-042368SemaxHJHJ-2603-V4363Nordanalyt2026-Q399.177.26106.3Supplier-supplied1MARGINAL
AX-2026-043283L-CarnosineCPCCPC-2603-G1651Medutest2026-Q398.1010.1291.8Supplier-supplied1FAIL
AX-2026-042802SelankGGPepsGGPE-2602-G2056Janoshik2026-Q398.747.0996.0Supplier-supplied0FAIL
AX-2026-042574TB-500ERPERP-2605-S8022VendorInvestigate2026-Q399.542.9196.4Buyer-sourced1MARGINAL
AX-2026-042347SemaglutideHJHJ-2608-C3931VendorInvestigate2026-Q398.803.41100.2Buyer-sourced1MARGINAL
AX-2026-043574N-Acetyl Semax AmideBCHBCH-2602-E8253Janoshik2026-Q397.758.8597.9Supplier-supplied1FAIL
AX-2026-043030RetatrutideKPKP-2607-H5219Kestrel2026-Q395.976.9597.1Supplier-supplied2FAIL
AX-2026-041453RetatrutideQYBQYB-2604-B5660VendorInvestigate2026-Q398.022.55—Buyer-sourced1MARGINAL
AX-2026-043106TirzepatideKPKP-2608-D5921PeptideMeter2026-Q398.905.45105.4Supplier-supplied2MARGINAL
AX-2026-042796SelankGGPepsGGPE-2602-G2056Janoshik2026-Q398.267.5697.5Buyer-sourced0FAIL
AX-2026-041886SemaglutideJEEPJEEP-2607-X3911Nordanalyt2026-Q399.194.0396.4Supplier-supplied2MARGINAL
AX-2026-041742TirzepatideFGPFGP-2603-L9714Janoshik2026-Q399.372.43105.5Supplier-supplied1MARGINAL
AX-2026-041337SemaglutideWWBWWB-2606-N3192Nordanalyt2026-Q398.964.81—Supplier-supplied1MARGINAL
AX-2026-042648Melanotan IIGGPepsGGPE-2603-P8735Janoshik2026-Q399.106.97—Supplier-supplied4MARGINAL
AX-2026-042535TesamorelinERPERP-2604-W7280Janoshik2026-Q399.193.8992.7Supplier-supplied1MARGINAL
AX-2026-042181IpamorelinHomopeptideHOMO-2608-A9045Janoshik2026-Q399.784.79—Supplier-supplied1MARGINAL
AX-2026-042172SemaglutideHomopeptideHOMO-2604-X8921Janoshik2026-Q399.645.1691.9Supplier-supplied1MARGINAL
AX-2026-042067SS-31 (Elamipretide)TFCTFC-2604-Y7472Kestrel2026-Q398.664.44—Supplier-supplied1MARGINAL
AX-2026-043365BPC-157CPCCPC-2602-W2646Medutest2026-Q398.562.80—Supplier-supplied1MARGINAL
AX-2026-042278SLU-PP-332HomopeptideHOMO-2602-Y2822Kestrel2026-Q399.714.42—Supplier-supplied0PASS
AX-2026-042180IpamorelinHomopeptideHOMO-2608-A9045Janoshik2026-Q399.394.74105.5Supplier-supplied1MARGINAL
AX-2026-041728CJC-1295 with DACQSCQSC-2602-E9474VendorInvestigate2026-Q398.427.04—Buyer-sourced1MARGINAL
AX-2026-043332LiraglutideCPCCPC-2602-G1978Janoshik2026-Q397.164.8891.3Supplier-supplied1FAIL
AX-2026-043180Kisspeptin-10GL BiochemGLBI-2608-N8085Janoshik2026-Q398.693.37103.8Supplier-supplied2MARGINAL
AX-2026-042577TB-500ERPERP-2605-S8022Janoshik2026-Q399.513.45—Supplier-supplied1MARGINAL